Secretion from activated platelets is thought to be a key step in hemostasis as well as in the post-thrombus sequellae of wound healing. Controlling platelet exocytosis offers a unique therapeutic opportunity to manipulate the microenvironment formed at the site of vascular damage. However, our understanding of the machinery that facilitates platelet granule release is still not sufficient to identify valuable drug targets. Our proposed studies seek to rectify this by delineating the molecular events required for platelet secretion. From past reports, it is clear that specific Soluble NSF Attachment Protein Receptors (v- and t-SNAREs) are required for platelet secretion. With this established, our goals are now expanded to define the roles of secretion in hemostasis and to identify the mechanisms by which the exocytosis machinery is regulated.
Two Specific Aims are proposed: 1) To assess the role of the v-SNARE, VAMP-8, in platelet function. Our work demonstrated that VAMP-8/endobrevin is required for platelet exocytosis.
Aim 1 will complete the characterization of this v-SNARE's role using specific experiments to define the in vivo and in vitro phenotypes of VAMP-8-/- platelets. Other experiments will address the sub-platelet distribution of VAMP-8 and characterize its interacting partners. 2) To identify and characterize the SNARE regulators that interact with and control the syntaxin t-SNAREs in platelets. Past studies assigned roles for SNAP-23, syntaxin 2, and 4.
This aim focuses on defining roles for known t-SNAREs regulators and identifying novel ones. The syntaxin-regulators Munc18, Munc13, DOC2, and tomosyn will be studied using biochemical techniques and a permeabilized platelet secretion assay. The experiments will expand our understanding of how these proteins mediate SNARE pairing and subsequent membrane fusion. In summary, the information gained from this proposal will identify new therapeutic targets to control hyperactive platelets and will provide diagnostic reagents to determine why hypoactive platelets are defective.

Public Health Relevance

Strokes and heart attacks are major killers in the United States. In both cases, the damage is caused by a loss of blood flow, usually because a blood clot has formed in the wrong place. Understanding all aspects of clot formation is critical to treating this problem. This application focuses on one aspect of clot formation, platelets. Specifically this application focuses on how platelets secrete components needed for clot formation. This work is of critical important because it will direct the development of future therapeutic agents needed to decrease the risk of spurious clot formation. ? ? ? ?

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Mondoro, Traci
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kentucky
Schools of Medicine
United States
Zip Code
Banerjee, Meenakshi; Whiteheart, Sidney W (2016) How Does Protein Disulfide Isomerase Get Into a Thrombus? Arterioscler Thromb Vasc Biol 36:1056-7
Ouseph, Madhu M; Huang, Yunjie; Banerjee, Meenakshi et al. (2015) Autophagy is induced upon platelet activation and is essential for hemostasis and thrombosis. Blood 126:1224-33
Nair-Gupta, Priyanka; Baccarini, Alessia; Tung, Navpreet et al. (2014) TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 158:506-21
Ye, Shaojing; Huang, Yunjie; Joshi, Smita et al. (2014) Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. J Clin Invest 124:4517-28
Jonnalagadda, Deepa; Sunkara, Manjula; Morris, Andrew J et al. (2014) Granule-mediated release of sphingosine-1-phosphate by activated platelets. Biochim Biophys Acta 1841:1581-9
Whiteheart, Sidney W (2013) ?-Granules at the BEACH. Blood 122:3247-8
Al Hawas, Rania; Ren, Qiansheng; Ye, Shaojing et al. (2012) Munc18b/STXBP2 is required for platelet secretion. Blood 120:2493-500
Jonnalagadda, Deepa; Izu, Leighton T; Whiteheart, Sidney W (2012) Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 120:5209-16
Matveeva, E A; Price, D A; Whiteheart, S W et al. (2012) Reduction of vesicle-associated membrane protein 2 expression leads to a kindling-resistant phenotype in a murine model of epilepsy. Neuroscience 202:77-86
Matveeva, Elena A; Davis, Verda A; Whiteheart, Sidney W et al. (2012) Kindling-induced asymmetric accumulation of hippocampal 7S SNARE complexes correlates with enhanced glutamate release. Epilepsia 53:157-67

Showing the most recent 10 out of 18 publications